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Abstract
Background: Analysis of microarray experiments often involves testing for the overrepresentation of pre-defined
sets of genes among lists of genes deemed individually significant. Most popular gene set testing methods assume
the independence of genes within each set, an assumption that is seriously violated, as extensive correlation
between genes is a well-documented phenomenon.
Results: We conducted a meta-analysis of over 200 datasets from the Gene Expression Omnibus in order to
demonstrate the practical impact of strong gene correlation patterns that are highly consistent across experiments.
We show that a common independence assumption-based gene set testing procedure produces very high false
positive rates when applied to data sets for which treatment groups have been randomized, and that gene sets
with high internal correlation are more likely to be declared significant. A reanalysis of the same datasets using an
array resampling approach properly controls false positive rates, leading to more parsimonious and high-
confidence gene set findings, which should facilitate pathway-based interpretation of the microarray data.
Conclusions: These findings call into question many of the gene set testing results in the literature and argue
strongly for the adoption of resampling based gene set testing criteria in the peer reviewed biomedical literature.
Background
Methods for statistical analysis of gene expression
microarrays are maturing rapidly, and there are a variety
of approaches to normalization, detection of differential
expression, clustering, and class prediction [1]. In many
experiments, a statistical test is performed to identify
genes significantly associated with experimental condi-
tion, clinical response, or other sample attributes. The
resulting list of significant genes may be so large that it
defies easy interpretation, and it is natural to seek a con-
cise, biological summary of results. One such approach
is gene set testing (sometimes called “pathway analysis”),
which detects over-representation of gene sets among
the list of significant genes. Gene sets may be curated
[2], or derived from databases such as Gene Ontology
(GO) [3] or Kyoto Encyclopedia of Gene and Genomes
(KEGG) [4].
The simplest approach to gene set testing relies on 2 ×
2 tables of gene set membership (in gene set or not) vs.
significance (significant or not). Gene set testing is often
performed using a c2 or Fisher’s Exact test [5], which rely
critically upon the assumption that individual genes, and
their associated test statistics, are independent, hereafter
referred to as the independence assumption [6]. Many
software tools use independence assumption methods
(reviewed in [7]) and these tools are employed by the
majority of publications using gene set testing (Figure
1a). However, independence of genes is a false assump-
tion for expression microarrays: indeed, correlation
forms the basis for informative techniques such as hier-
archical clustering [8,9]. Several authors have noted, via
simulation or analysis of a few experimental data sets,
that correlation adversely affects the selection of signifi-
cant gene sets [6,10-13]. Investigators who have recog-
nized this problem employed resampling-based
approaches that maintain the correlation structure of the
expression data and produce an empirical estimate of
gene set significance [14,15]. Resampling approaches
have also been integrated into many software tools to
address this problem [2,10,16-19]. Nevertheless, the use
of independence assumption-based methods continues to
increase (Figure 1b).
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As the independence assumption is clearly violated for
gene expression microarrays [11,20,21], how can we
explain the persistent use of independence methods?
Independence assumption methods may appeal to the
belief that the occurrence of multiple members of a
gene set on a list of significant ones “cannot be due to
chance.” Indeed, in a post-hoc interpretation, the fact
that the genes within a set are correlated is often, incor-
rectly, viewed as reinforcing the biological plausibility
[5,22], despite evidence presented here and elsewhere
that the presence of correlation increases false-positive
rates. It is conceivable to argue that correlation within a
gene set itself provides additional information, if such
correlation varied substantially across different experi-
ments. However, as we show here, correlation within a
gene set is largely a persistent property that is preserved
across a wide variety of sample sources and experimen-
tal conditions.
Here, we clearly demonstrate that the correlation
between genes inflates the false positive rate, that the
magnitude of this inflation is quite high, and that a sim-
ple resampling method for gene set testing produces the
correct false positive rate. We use a large number (over
200) of real experimental datasets, not simulated data,
to show that 1) inter-gene correlation is a pervasive fea-
ture of gene sets, regardless of experimental condition,
2) inter-gene correlation inflates the apparent signifi-
cance of gene set statistics, leading to an increase in
false positives, and 3) array resampling approaches can
correctly address the problem of inter-gene correlation.
As there are several existing tools that use resampling
approaches to determine functional enrichment among
significant gene lists, we argue that the naïve approaches
should no longer be used and should be replaced by
tools employing a resampling approach.
Results
We investigated the degree to which correlation within
gene sets is preserved across multiple experiments by
analyzing Gene Expression Omnibus [23] data from two
human (HG-U133A, HG-U95A), and two mouse (MG-
U74A, MOE430A) arrays. Datasets with 20 or more
samples were used, resulting in 202 datasets and 8,656
arrays. For each dataset we calculated the mean correla-
tion for genes within each GO category or KEGG
pathway. The results give strong evidence of the repro-
ducibility of internal correlations (low standard errors in
Figure 2), with strong agreement of gene set correlations
between platforms (Spearman cor.: 0.719 - 0.862) (Fig-
ure 2). Correlation within gene sets is thus closely asso-
ciated with gene set membership, regardless of
experimental condition [9]. The samples represent a
wide variety of experiments, including in vitro cell lines,
sex comparisons, multiple cancer sub-types, tissues, and
diseases. Clearly, in contrast to previous assertions
[5,22], mere correlation of genes within gene sets and
pathways is commonplace, and does not necessarily
reflect unique features of the experiment at hand. As
Figure 2 shows, correlation within gene sets covers a
wide range, and is generally higher than correlation of
randomly selected genes. The correlations within gene
sets are much higher than the correlation of all tran-
scripts on each platform with each other (Figure 2, red).
Of course, genes from different sets can be correlated
(even highly so), but we confine our focus here to pre-
defined gene sets.
One simple way to describe the effect of correlation is
through a standardized enrichment test statistic. Let z
be the signed square root of the independence assump-
tion c2 statistic (see Methods). Under the null hypoth-
esis (no enrichment), z should have approximately mean
Figure 1 Publications that assume independence between genes (light grey) greatly outnumber publications that use array
resampling methods (dark grey). Panel (a) shows the cumulative number of publications and panel (b) shows the number of publications
using each method per year. Year of publication is displayed on the horizontal axis.
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0 and variance 1. However, the true variance can be
much greater, with an increase proportional to (m - 1)r
(see Methods), where m is the number of genes in the
set, and r is the average correlation among genes in the
set (excluding self-correlations). Independence assump-
tion methods assume r = 0, implying that the variance
equals 1. However, if the average internal correlation of
a gene set is positive, then the variance of z can be
greatly inflated, even if this correlation is modest,
depending on the gene set size m.
To empirically demonstrate that variance inflation
results in the false significance of gene sets, we ran-
domly permuted the sample labels associated with each
of the 202 Gene Expression Omnibus data sets 10,000
times, and then performed a gene set analysis on each
permutation using a common independence assumption
method. For each permutation a list of “significant”
genes with p ≤ 0.05 (using a t-test or F-test, as appropri-
ate) was created in order to have a meaningfully-sized
gene list, and the standard c2 statistic was used to assess
the significance of each gene set. A gene set was called
significant if it had a Bonferroni-corrected (for the num-
ber of sets) c2 p-value ≤ 0.05. Note that this is a highly
conservative threshold, intended to guarantee that no
more than 5% of the permutations result in one or
more gene sets (falsely) called significant. The gene set
null hypothesis is that each gene set has the same pat-
tern and proportion of differentially expressed genes as
any other set [24]. Permutation of the sample labels
induces the null hypothesis for each gene, and thus no
gene sets should exhibit enrichment for differential
expression. Hence, any gene set declared significant is a
false positive.
To determine the overall experiment-wise increase in
false positives, we counted the number of permutations
in which at least one gene set was declared significant,
using the Bonferroni-corrected 0.05 threshold. If the
independence assumptions were true, no more than 5%
Figure 2 The inter-gene correlation within GO categories is consistent across experiments and platforms. Mean correlation among
genes in GO categories (a,b) and KEGG pathways (c,d) on two human (a,c) and two mouse (b,d) microarray platforms. The correlation of all
transcripts with all transcripts on each platform is shown in red. Spearman correlations of the correlations are in upper right. Crosses
represent +/- 1 standard error on each axis.
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of the permutations would give rise to significant gene
sets. However, the observed proportion is much higher
(Figure 3; Additional file 1, Figure S1). False positive
rates often exceed 50%, and in some cases are above
80%, and are even higher when the False Discovery Rate
(FDR) is used as a multiple comparison correction.
Clearly such high false positive rates have serious impli-
cations for the conclusions drawn by any study which
uses independence assumption methods to provide bio-
logical interpretation of microarray data.
In addition, as predicted, we found that variance infla-
tion is directly related to the false-positive rate for a
gene set. For each GO Biological Process (Figure 4) or
KEGG pathway (Additional file 1, Figure S2), we show
that the empirical variances of the standardized enrich-
ment statistic (which often greatly exceed 1) are highly
correlated with the per-category false positive rates. Spe-
cifically, for each gene set, we calculated the variance of
the square root of the c2 statistic across all permuta-
tions, and plotted it against the number of permutations
in which that gene set was called “significant” using a
Bonferroni correction.
Fortunately, the shortcomings of independence
assumption methods can be addressed through the use
of resampling-based methods. These methods use the
resampling data to construct an empirical null distribu-
tion for the gene set test statistics, taking into account
the correlation structure between genes and providing a
more accurate assessment of statistical significance. Sev-
eral existing tools use resampling based approaches
[2,16-19], either permuting sample labels relative to
gene expression, or performing bootstrap resampling
[24]. We empirically investigated the performance of the
permutation approach, which we will refer to as “resam-
pling” to avoid confusion with the permutations
described above. The sample labels for each data set
Figure 3 False positive rates are greatly increased using independence assumption methods, GO Biological Process categories. The
proportion of permutations in which at least one GO Biological Process category is called significant using an independence assumption
method with a Bonferroni correction (a = 0.05), the Benjamini & Hochberg FDR (a = 0.05, 0.10), and the resampling approach described in this
manuscript. Red lines = 5% & 10%.
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were resampled without replacement 10,000 times, and
the resulting enrichment statistic distribution was used
to obtain an empirical p-value for each gene set. For
example, if the observed enrichment statistic for a gene
set was greater than or equal to 99% of the resampled
enrichment statistics, a p-value of 0.01 was assigned to
that gene set. As the resampling units are entire arrays,
correlation between genes is maintained under resam-
pling. Therefore the effects of correlation within gene
sets apply to both the resampled and observed data,
properly controlling the false positive rate. To demon-
strate that the resampling approach correctly controls
the false positive rate, we applied the resampling proce-
dure to all permutations of all 202 datasets, using the
same c2 statistic as above. Using the empirical distribu-
tion of test statistics under resampling to generate the
gene set p-value, proper control of the false positive rate
was obtained (Figure 3; Additional file 1, Figure S1,
right-most boxplots).
While the analyses above clearly show that gene corre-
lation increases the false positive rate for independence
assumption methods, it may be tempting to argue that
correlation does not affect false positive rates in real
datasets, which presumably include true enrichment. To
investigate this, we computed the proportion of
observed datasets in which each gene set was declared
significant by the independence assumption method,
and compared these values to the previously generated
proportions observed under random permutation. The
results for GO Biological Process categories (Figure 5)
and KEGG pathways (Additional file 1, Figure S3)
demonstrate a strong relationship. In other words, cate-
gories declared statistically significant by independence
assumption methods in actual datasets are often
declared significant when treatment assignments are
made purely at random. This strongly calls into question
the biological conclusions drawn from such analyses, as
we have demonstrated that such correlation is a predo-
minant source of misinterpretation, rather than a biolo-
gical confirmation. Indeed, some gene sets have such
high false positive rates (Figures 3 and 5) under inde-
pendence assumption that one or more sets may be
Figure 4 Variance inflation due to correlation of gene expression increases the false positive rate, even when using a Bonferroni
correction. The percentage of permutations in which at least one GO Biological Process category was called significant is shown versus the
variance of the gene set statistic, for two human (a,b) and two mouse (c,d) arrays. Spearman correlations are in the upper left of each panel.
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found significant in multiple studies, further enhancing
apparent biological confirmation.
Discussion
The most straightforward strategy for gene expression
analysis is to focus on individual genes for which
expression differs among samples of interest. Such
approaches often consider the genes selected based on
significance thresholds, with the goal of predicting or
finding associations with disease prognosis [25], adverse
response to a chemical [26], disease pathogenesis [27],
or identification of key genes in a pathway that may
serve as biomarkers [28]. Although useful, gene-by-gene
analyses may not account for the complex underlying
biology where the transcriptional programs are distribu-
ted across an entire network of genes, and may involve
only subtle changes among individual genes. Even for
gene-by-gene analysis, the presence of strong correla-
tions is increasingly recognized as a potentially compli-
cating feature. For example, surrogate variable analysis
[29] attempts to reconstruct latent variables which
explain variation in gene expression, which rely on
gene-gene correlation in an essential manner.
Gene set testing, in which enrichment of significant
differentially expressed genes is sought among gene sets,
is by now a standard method to provide biological inter-
pretation for gene expression data. Groups of genes
with a common biological function, cellular localization,
regulation, or chromosomal location may hold addi-
tional clues regarding underlying biology, or potentially
improve prediction or classification. While many easy-
to-use tools have been developed to facilitate pathway-
or gene set-based analysis, inter-gene correlation within
gene sets violates the independence assumption that
underlies many gene set analysis methods. Indeed, our
meta-analysis demonstrates that the correlation patterns
persist across a wide variety of mouse and human
experiments. Thus, we argue that correlation patterns
should largely be viewed in terms of their effects on
false positives, as we find no evidence that correlation
Figure 5 GO Biological Process categories that are called significant by chance under permutation are likely to be called significant in
the observed data. The proportion of times that a category is declared significant under permutation is plotted versus the proportion of times
it is called significant in the observed data. Spearman correlations in upper left corner.
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within the gene set confers additional plausibility to a
gene set finding.
Though it may be viewed as a technical matter, vio-
lation of the independence assumption is not a mere
statistical detail. It is a tangible phenomenon that
increases the chance of falsely declaring a gene set sig-
nificant. The false positive rates established by our
study are very high - sometimes an order of magnitude
beyond the intended false positive rate. Array resam-
pling methods correctly handle inter-set correlation
and are not subject to these high false positive rates.
Barry et al. [24] describe investigations of power and
provides context on the meaning of type I error con-
trol for resampling-based methods. The null distribu-
tion induced by permutation here is a special case of
the expanded definition in [24], because the null
hypothesis holds for each gene. Bootstrap resampling
methods were shown in [24] to have more power than
array permutation methods in simulated and real data
sets, and expansions beyond the existing resampling
approaches are worthy of investigation. There are a
wide number of available packages that implement
these methods, such as GSEA [2], Catmap [16], SAFE
[17], ErmineJ [10], and SAM-GS [18].
Several methods have been proposed which use mul-
tivariate modeling of array data to perform gene set
testing [19,30,31]. Although comparisons using such
approaches were not a main focus, we briefly tested
whether these methods correctly control the false posi-
tive rate, by permuting the sample labels for one data
set (GDS266) 1,000 times and counting the number of
permutations in which at least one GO BP category
was called significant using a 5% FDR. The globaltest
procedure [19] uses a score-based test statistic to test
for correlation of an entire set of genes with clinical
outcome, and can be used for gene set testing. The
parametric version of globaltest incorporates the
observed correlation structure, and is compared to a
c2 distribution. However, we found that 94% of permu-
tations called at least one GO BP category significant,
with a median of 10 categories called significant in
each permutation, suggesting difficulties in proper con-
trol of the false positive rate. It is worth noting that
use of empirical covariance estimates is extremely
challenging, especially when gene sets are larger than
the sample size. GlobalANCOVA [30] fits a linear
model between each gene and the experimental covari-
ates, and uses permutation testing to obtain empirical
p-values. We found that GlobalANCOVA found no
significant GO BP categories under permutation, sug-
gesting that GlobalANCOVA properly controls the
false positive rate, and is perhaps conservative. Several
related methods have been proposed [31,32] that test
for differential expression or predictive ability of sets
of genes. Many of these approaches attempt to incor-
porate gene-gene correlation structure parametrically,
and are thus computationally appealing. However, until
more comprehensive investigations have been per-
formed for the multivariate procedures, it seems pru-
dent to examine the false positive rate in 1,000
permutations of their data before accepting the results
at face value. Other investigators have explored more
complex procedures involving stochastic dependence
[33], while deeper explorations of random-set methods
[34] may be valuable, but still essentially rely on inde-
pendence assumptions. Several other methods are
reviewed and compared in [35-37]. In summary,
despite the availability of software and a wide array of
methods that address inter-gene correlation, the litera-
ture on microarray analysis is rife with studies that use
independence assumption methods.
As the use of independence assumption methods in
gene array studies is widespread, we conclude that pub-
lished false gene set findings may be common. The precise
impact of the overly optimistic statistical support for many
gene set findings is difficult to assess, because we do not
know the underlying truth; however, a basic requirement
of a valid statistical test is that it controls false positives
under the null hypothesis, and we have clearly demon-
strated here that methods that rely on independence
assumptions are therefore invalid in this sense.
It should be acknowledged that very small microarray
studies may have too few samples to support permuta-
tion. For such studies, a strong statistical result from an
independence assumption-based method should be sup-
ported by corroborating biological evidence, and even
then be interpreted with caution.
Conclusions
Here, we have demonstrated, using over 200 real experi-
mental data sets that independence assumption methods
for gene set enrichment suffer from such a high false
positive rate that they should not generally be used.
Array resampling methods, which correctly control the
false positive rate, should be used by investigators,
incorporated into existing routines and workflows, and
insisted upon by reviewers of scientific manuscripts. We
strongly encourage the use of tools such as GSEA [2],
SAFE [17], Catmap [16], ErmineJ [10], SAM-GS [18] or
others which employ resampling-based methods to
determine gene set significance.
Methods
Compilation and Categorization of Pathway Tools
Using the list of pathway tools compiled by [7], we
downloaded all citations for each tool from the ISI
Web of Knowledge (http://apps.isiknowledge.com/,
accessed March 31, 2010). The manuscripts (for the
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period from 2002 to 2009) were divided into those
using resampling- or independence assumption-based
methods as detailed in [7]. Reviews and manuscripts
that did not explicitly state the pathway selection
method were not counted.
Gene Expression Omnibus Datasets
Using the GEOmetadb [38] and GEOquery [39] packages
from Bioconductor, Gene Expression Omnibus was quer-
ied in April 2009 for all datasets run on the Affymetrix
(Santa Clara, CA) HG-U133A, HG-U95A, MG-U74A
and MOE430A that contained 20 or more samples.
There were 74, 43, 59 and 26 datasets for each array,
respectively. The data was used as normalized by the sub-
mitters. The datasets are listed in Additional file 2, Tables
S1 through S4.
Correlation Analysis and Variance Inflation
For each array platform, the genes in each GO category
from all ontologies and each KEGG pathway with
between 5 and 5000 genes were collected. The mean
Pearson correlation was taken as the mean pairwise cor-
relation between all genes in the gene set, excluding the
unit correlation of each gene with itself. For each gene
set, the mean and standard error of the correlations in
all datasets for a single platform was calculated. The
variance inflation factor, used here only to provide moti-
vation for our empirical results, is derived as follows.
We construct the 2 × 2 table of gene significance (using
nominal p-value threshold a) and membership in a gene
set of size m. A valid statistic, and approximately
equivalent to the standard c2 statistic, can be con-
structed from the single table entry for “significant and
in the gene set,” assuming that no substantial enrich-
ment is expected in the remaining genes. Using i to
index the genes in the set, we have observed entry
O I pii
m
= ≤
=
∑ [ ]1 , which has variance
   
 
( ) cov( [ , ])
( ) ( ) ( [
1
1
1
2
− + ≤ ≤
= − + − ≤
= ≠∑ ∑im i j i j
i
I p p
m m m I pcorr    ], [ ]) ( ),I p j ≤ −1
where corr( [ ], [ ])I p I pi j≤ ≤  is the average correla-
tion of the significance indicators for different genes i
and j in the gene set. Dividing through by the indepen-
dence assumption variance ( var ( )IA = −
=
∑  11im ), we
obtain var( ) / var ( ) ( ) ( [ ], [ ])O O m I p I pi jIA corr= + − ≤ ≤1 1   . The
average correlation of significance indicators has a non-
linear relationship with the original within-set gene-gene
mean correlation r. However, observed variance infla-
tion values are roughly proportional to mr, as illustrated
in Additional file 1, Figure S4. The concept of variance
inflation is described more extensively in [24].
Independence Assumption Analysis
GO Biological Process categories and KEGG pathways
with between 25 and 5000 genes were used to satisfy
the assumptions of the c2 test. Based on the experi-
mental annotation provided in Gene Expression Omni-
bus for each dataset, either a Student ’s T-test or
analysis of variance (ANOVA) was carried out on each
gene to select differentially expressed genes between
the experimental classes provided in the annotation.
Significant genes were selected using a nominal
p-value of 0.05. A one-sided standard c2 test (i.e. to
test for enrichment only) was performed on each gene
set, and significant gene sets were selected at a Bonfer-
roni corrected p-value of 0.05. Both GO Biological
Process categories and KEGG pathways were analyzed
using this approach.
Permutation Analysis
For each dataset, either a Student’s T-test or ANOVA
was carried out on each gene to select differentially
expressed genes between experimental classes at a nom-
inal p-value of 0.05. The one-sided c2 test statistic was
used for gene set testing. The sample labels on the
arrays were then permuted, and the entire analysis was
repeated 10,000 times, resulting in a matrix of gene set
statistics with one row for each gene set and one col-
umn for each permutation.
Resampling Analysis
The data was permuted as above and the permutation
matrices containing gene set statistics were retained.
Empirical p-values for each gene set were calculated as
the proportion of permutations for which the c2 statistic
was greater than or equal to the observed c2 statistic. A
gene set was called significant if its Benjamini & Hoch-
berg FDR adjusted p-value was 0.05 or 0.10. GO Biolo-
gical Process categories and KEGG pathways were both
analyzed using this approach.
Statistical Analyses were conducted using R, version
2.8.1 [40] and array annotation from Bioconductor, ver-
sion 2.3 [41].
Additional material
Additional file 1: Additional file 1, Figure S1 False positive rates are
greatly increased using independence assumption methods, KEGG
pathways. The proportion of permutations in which at least one KEGG
pathway is called significant using an independence assumption method
with a Bonferroni correction (a = 0.05), the Benjamini & Hochberg FDR
(a = 0.05, 0.10), and the resampling approach described in this
manuscript. Additional file 1, Figure S2. Variance inflation due to gene
expression correlation increases the false positive rate, even when using
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a Bonferroni correction. The percentage of permutations in which at
least one KEGG pathway was called significant is plotted versus the
variance of the standardized gene set statistic (signed square root of the
c2 statistic). Results are shown for two human (a,b) and two mouse (c,d)
arrays. Additional file 1, Figure S3. KEGG pathways that are called
significant by chance under permutation are likely to be called significant
in the observed data. The proportion of times that a KEGG pathway is
declared significant under permutation is plotted versus the proportion
of times it is called significant in the observed data. Additional file 1,
Figure S4. The variance of the gene set statistic (signed square root of
c2 statistic) increases in proportion to the variance inflation factor (VIF =
1 + (m-1)r). The VIF is plotted versus the variance of the gene set
statistic versus for two human (a, b) and two mouse (c, d) arrays.
Spearman correlations are shown in the upper right corner.
Additional file 2: Additional File 2. Table S1. HG-U95A array
datasets. PubMed, GEO and other IDs and descriptions of the datasets
used. Additional File 2. Table S2. HG-U133A array datasets. PubMed,
GEO and other IDs and descriptions of the datasets used. Additional
File 2. Table S3. mgu74a array datasets. PubMed, GEO and other IDs and
descriptions of the datasets used. Additional File 2. Table S4. moe430a
array datasets. PubMed, GEO and other IDs and descriptions of the
datasets used.
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